Trading Summary - January 18. A satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
266
Trading Summary - January 18.

A satisfactory status quo day for $SFLM in the same bottom range - less than 25% of target price .02+ range (ie anything under .0052) - while OTC market top traders needed to concentrate elsewhere all day on multiple moves and loading opportunities on Watch List tickers - primarily $GTEH $NECA $FBCD $APRU $BRGO $PSRU.

All day there was f urther jockeying for position in the .0017 > .0019 range with buys on both the bid and the ask by traders looking to increase their overall inventory of shares for the expected move into the .01 > .02+ range ahead.

Closed effectively at .0020 with only a mickey mouse amount at .0019.

None of the asks are of any significance to hinder a quick break above .0030 towards the .01 > .02 range needed for OTCQB uplisting - and as appropriate to its $10.241M revenue market cap - whenever the top traders of $SFLM decide to concentrate on it.

As shown in the report for December 31, 2021, the vast majority of shares are held with a cost basis under .0052 now with the balance above held by longs who didn't sell for a tax loss as it is self-evident the price should be going above .02 at some point in 2022.

Overall, 3M shares were bought today - all at .0017 > .0019.

New interest traders / alerters + long-term traders with significant followings as at January 16 numbered at least 165 - up another 8 in the previous 7 days. List here:

https://investorshangout.com/post/view?id=6322539

Particular points they like are:

- Real revenue of $10.241M in 2021.

- Revenue growth of 34.75% in 2021 - beating the target of 30%.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases at end-Q3.

- Assets of $1.398M at end-Q3.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- How thin it is into the .01 > .02 range.

- Multiple catalysts ahead throughout 2022.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .063 > .1100 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .063 > .1100.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150, $15K profit at .02, $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated January 16 - here:

https://investorshangout.com/post/view?id=6322549

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 on my Watch List.

It is the joint #1 Top Profit Pick for the whole of 2022 (with $ENZC).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

Watch for the next PR which I would expect to cover the excellent Q3 results, the sales since in Q4, acquistions of collectibles companies and expansion of the NFT Division with artists recruited Nationwide.

The Share Structure was updated after the close on January 3 - again showing no change and confirming no dilution for 3+ months - with the Unrestricted O/S remaining at a low 837M.

Revenue for the the first 2 weeks of 2022 is at least $440K - which pro-rata would equate to $11.471M for the year.

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZ MOUSE Revolutionizes Multi-Device Computing Control

Updated Category News Views 14

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 173

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Tax Planning vs. Preparation: Strategic Differences

Updated Category News Views 68

Tax Strategy: Not All About April 15 Ready to fend off that taxman? Well, don’t just wait for that dreaded April deadline. Greg Harrison over at Harrison Financial Management spills some wisdom on the oft-overlooked nuances between tax planning and tax preparation. It’s not just semantics; it’s the difference between shaping your financial future and simply...

Continue Reading
Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Updated Category News Views 22

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

Continue Reading
NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 57

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
Xinjiang Women Embrace New Horizons in Tianshan Peaks

Updated Category News Views 89

Scaling New Heights in Xinjiang Up there on the Tianshan Mountains, looking past those towering cliffs, what catches the eye isn't just breathtaking views but rising opportunities. In the land of Xinjiang, far from the bustling metropolises, young women are finding platforms to not just exist but to thrive. City by city, the narrative is changing as these women carve...

Continue Reading
Stocks Jump Ahead of Critical Inflation Reports

Updated Category News Views 19

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

Continue Reading
Pak Mail Expands: Franchisee Adds Location Fast

Updated Category News Views 47

Franchise Growth: Adding Another Brick When's the last time you heard of a franchisee eager enough to nab a second location? Well, that's exactly what's happening with Manny Zussman, who’s decided his Boulder Pak Mail outlet wasn’t keeping him busy enough. This entrepreneurial spirit's on full display as he's launching another Pak Mail over in Westminster, Colorado....

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 139

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Unquiet Nights' New Tune Echoes Rome's Eternal Lingering

Updated Category News Views 53

Irish Rockers Unquiet Nights Celebrate a Poignant Release Ever heard of a band that takes its darn sweet time? Well, Unquiet Nights just dropped a single after sitting on it for a solid 15 years. 'Last Days of Rome' isn’t just a new tune; it’s a love letter to both music and the eternal echoes of Rome’s history. These Belfast rockers have been crafting this piece...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis and NFL Stars Unite for Prostate Cancer Awareness

Updated Category News Views 168

Novartis Collaborates with NFL Legends for Health Awareness In an inspiring partnership, several NFL icons, including Coach Bruce Arians, Rob Gronkowski, and George Kittle, are joining forces with Novartis to elevate awareness about prostate cancer screening. Their initiative is particularly significant as statistics reveal that one in eight men will encounter this...

Continue Reading
MassageLuXe Celebrates 100th Spa and Expands Franchise Network

Updated Category News Views 192

MassageLuXe Celebrates 100th Location Milestone MassageLuXe, a prominent luxury spa franchise renowned for its exceptional massage therapy and skincare services, recently marked an impressive milestone with the grand opening of its 100th spa. This achievement not only highlights the brand's significant growth but also reflects its commitment to enhancing wellness in...

Continue Reading
Women's Workforce Progress: Gains and Challenges Ahead

Updated Category News Views 268

Analyzing Women's Workforce Gains and Ongoing Challenges Five years following the pandemic, women's employment has surged to unprecedented levels, while men are increasingly engaging in unpaid caregiving roles. However, significant disparities remain—particularly for mothers and women of color—alluding to the necessity of maintaining this positive momentum and seeking...

Continue Reading
Market Insights: Man Group PLC's Engagement with American Axle

Updated Category News Views 131

Understanding Man Group PLC's Position Man Group PLC is a distinguished player in the investment management landscape. With a robust portfolio and a commitment to innovative strategies, they have established a strong presence in various sectors, including automotive manufacturing. Their recent engagement with American Axle & Manufacturing Holdings Inc. showcases their...

Continue Reading
CVC Challenges Deutsche Bahn's Decision on Schenker Sale

Updated Category News Views 129

CVC Questions Deutsche Bahn's Schenker Sale Decision In a noteworthy development, CVC, a financial investor, is stepping up to impact the sale of Schenker, the logistics division currently owned by Deutsche Bahn. A recent letter reveals CVC’s strong position, urging the German state railway to reconsider its $16 billion deal with Denmark's DSV. This communication raises...

Continue Reading